Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JOYY
2001
JOYY Inc
JOYY
$3.73B
| $18.9M | ﹤0.01% |
289,034
+25,626
| +10% | +$2.18M |
|
2002
CAE Inc. Common Shares
CAE
$8.51B
| $18.9M | ﹤0.01% |
620,458
+56,040
| +10% | +$1.71M |
|
|
TRHC
2003
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $18.9M | ﹤0.01% |
378,617
+20,509
| +6% | +$918K |
|
2004
StepStone Group
STEP
$3.83B
| $18.9M | ﹤0.01% |
549,972
+171,609
| +45% | +$5.71M |
|
2005
Stock Yards Bancorp
SYBT
$2.62B
| $18.9M | ﹤0.01% |
371,709
+5,073
| +1% | +$262K |
|
2006
Advantage Solutions
ADV
$527M
| $18.9M | ﹤0.01% |
70,112
+26,844
| +62% | +$8.29M |
|
2007
Central Garden & Pet Co Class A
CENTA
$2.39B
| $18.9M | ﹤0.01% |
488,964
-329,432
| -40% | -$13.5M |
|
2008
Bausch Health
BHC
$2.62B
| $18.8M | ﹤0.01% |
645,782
+20,489
| +3% | +$621K |
|
|
WOW
2009
DELISTED
WideOpenWest
WOW
| $18.8M | ﹤0.01% |
905,360
+50,272
| +6% | +$789K |
|
2010
SkinHealth Systems
SKIN
$90.6M
| $18.7M | ﹤0.01% |
+1,114,141
| New | +$15.2M |
|
|
JAMF
2011
DELISTED
Jamf
JAMF
| $18.7M | ﹤0.01% |
557,418
+90,972
| +20% | +$3.1M |
|
2012
Orion
OEC
$385M
| $18.7M | ﹤0.01% |
983,843
+27,723
| +3% | +$549K |
|
2013
DMC Global
BOOM
$149M
| $18.7M | ﹤0.01% |
332,237
+81,904
| +33% | +$4.5M |
|
2014
Brown-Forman Class A
BF.A
$12.9B
| $18.7M | ﹤0.01% |
264,565
+5,429
| +2% | +$387K |
|
|
YMAB
2015
DELISTED
Y-mAbs Therapeutics
YMAB
| $18.6M | ﹤0.01% |
551,047
+76,929
| +16% | +$2.47M |
|
2016
Invesco Mortgage Capital
IVR
$757M
| $18.6M | ﹤0.01% |
477,171
+113,462
| +31% | +$4.3M |
|
|
AGEN
2017
Agenus
AGEN
$326M
| $18.6M | ﹤0.01% |
172,535
+29,704
| +21% | +$2.23M |
|
2018
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $18.5M | ﹤0.01% |
666,804
-58,026
| -8% | -$1.59M |
|
2019
Globalstar
GSAT
$10.8B
| $18.5M | ﹤0.01% |
693,273
+339,968
| +96% | +$6.67M |
|
2020
Ocular Therapeutix
OCUL
$1.84B
| $18.5M | ﹤0.01% |
1,304,799
+75,191
| +6% | +$1.14M |
|
2021
iQIYI
IQ
$1.26B
| $18.5M | ﹤0.01% |
1,195,699
+84,782
| +8% | +$1.26M |
|
2022
Zumiez
ZUMZ
$345M
| $18.4M | ﹤0.01% |
376,544
+24,607
| +7% | +$1.1M |
|
2023
e.l.f. Beauty
ELF
$4.87B
| $18.4M | ﹤0.01% |
678,266
+13,984
| +2% | +$400K |
|
|
TVTY
2024
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $18.4M | ﹤0.01% |
699,225
+19,791
| +3% | +$497K |
|
2025
Clear Channel Outdoor Holdings
CCO
$1.23B
| $18.4M | ﹤0.01% |
6,953,728
+3,124,548
| +82% | +$7.49M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.